Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL
BlackRock, Inc. reported a 9.90% stake in Rigel Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc. reported a 9.90% stake in Rigel Pharmaceuticals, Inc., 1,748,107 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 1,748,107
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 9.90% | 1,748,107 |
Source
Related
- Rigel Pharmaceuticals, Inc.
- BlackRock, Inc.
- Rigel Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Form 4 · Schorno Dean L · Sep 3, 2026
- Form 4 · Santos David A · Sep 3, 2026
- Form 4 · Rodriguez Raul R · Sep 3, 2026
- Form 4 · Furey Raymond J. · Sep 3, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026